Trial Profile
Efficacy of Pemetrexed in combination with carboplatin in untreated patients with non-small cell lung cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Nov 2015
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 30 Nov 2015 New trial record
- 01 Mar 2011 Recruitment completed, according to results published in the Anticancer Research.